Actithera
Cambridge
About Actithera
Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and larger therapeutic windows.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $75.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2025)
- Website: actithera.com
- Phone: +1-617-780-8045
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/actithera-35005 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.